Assistant Professor Camilla Gustafsen
Aarhus University Hospital, Aarhus (Denmark)
SorLA is a novel high affinity PCSK9 receptor that inhibits its inactivation by furin
Event: ESC Congress 2016
Topic: Metabolism and metabolic syndromes
Session: Metabolism and hypertrophy
ESC 365 is supported by
